Skip to main content
OpenTrials
Completed

NCT Number: NCT04392362

A Trial to Compare American Heart Association (AHA) and Simple (SIM)Method to Give Adenosine to Treat Supra-ventricular Tachycardia (SVT)

Study to compare non inferiority of giving adenosine with the simplified method vs the AHA method

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Supra-ventricular Tachycardia

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Steve Biko hospital

Pretoria, Gauteng, 0001, South Africa

About this study

tle: A randomised controlled trial of the standard versus a simplified adenosine administration method in the treatment of adult patients with supra- ventricular tachycardia (SVT

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Svt
  • normal blood pressure
  • normal mentation
  • Give consent

Exclusion criteria

  • recent coffee
  • Allergy to adenosine
  • Asthma
  • cardiac operations

Treatment and study plan

Adenosine

Drug

A vial of adenosine with 6mg

Primary outcomes

  1. The Number of Patients With First Dose Successful Termination of the Supraventricular Tachycardia to a Sinus Rhythm of Less Than 140 With the AHA Versus a Simplified Method of Adenosine Administration

    Time frame: 10 seconds

    The primary outcome is the rhythm of conversion to a sinus rhythm less than 140 beat per minute.

Sponsors and collaborators

Lead sponsor

University of Pretoria

Other

Registry information

Official study title

A Randomised Controlled Trial of the Standard Versus a Simplified Adenosine Administration Method in the Treatment of Adult Patients With Supra- Ventricular Tachycardia (SVT)

Acronym: AHAvsSIM

Important dates

Study start
2018
Primary completion
2020
Study completion
2020
First posted
May 18, 2020
Registry last updated
Jun 25, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.